Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma

Rationale: Metastatic melanoma is the most aggressive and dangerous form of skin cancer. The introduction of immunotherapy with Immune checkpoint Inhibitors (ICI) and of targeted therapy with BRAF and MEK inhibitors for BRAF mutated melanoma, has greatly improved the clinical outcome of these patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruggiero, Ciro Francesco, Fattore, Luigi, Terrenato, Irene, Sperati, Francesca, Salvati, Valentina, Madonna, Gabriele, Capone, Mariaelena, Valenti, Fabio, Di Martino, Simona, Mandoj, Chiara, Liguoro, Domenico, Castaldo, Vittorio, Cafaro, Giordana, Simeone, Ester, Vanella, Vito, Russillo, Michelangelo, Conti, Laura, Cuda, Giovanni, Giannarelli, Diana, Ascierto, Paolo Antonio, Mancini, Rita, Ciliberto, Gennaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691363/
https://www.ncbi.nlm.nih.gov/pubmed/36438490
http://dx.doi.org/10.7150/thno.77761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691363/
https://www.ncbi.nlm.nih.gov/pubmed/36438490
http://dx.doi.org/10.7150/thno.77761

Ejemplares similares